(Q44199016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Simvastatin treatment in the SLO syndrome: a safe approach? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Ingemar Björkhem

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Lena Starck

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Anita Lövgren-Sandblom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medical Genetics Part A

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

183-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

Characterization of photosensitivity in the Smith-Lemli-Opitz syndrome: a new congenital photosensitivity syndrome

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Comparative tolerability of the HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

The effect of hypocholesteremic agents on myelinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

The Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Molecular cloning and expression of the human delta7-sterol reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Abnormal bile acids in the Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Prenatal diagnosis of Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

New treatment strategy for Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

Detection of defective 3 beta-hydroxysterol delta 7-reductase activity in cultured human fibroblasts: a method for the diagnosis of Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10722

21 January 2018

Identifiers

DOI

10.1002/AJMG.10722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12407710%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference